SCHEMBL8081931

SCHEMBL8081931

CCOC(=O)c1cccc(N(C(N)=O)[C@@H]2CCCCNC2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ ALOX5 P09917 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37
▸ NCSTN Q92542 1/20 0.37
▸ APH1A Q96BI3 1/20 0.37
▸ PSENEN Q9NZ42 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CYP4F2 P78329 1/20 0.37
▸ CYP4A11 Q02928 1/20 0.37
▸ GALR1 P47211 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081933 1.00 NPC1 (0.42) NPC1RAB9AALOX5ATMALDH1A1
SCHEMBL8095765 0.71 ALDH1A1 (0.52) NPC1RAB9AALDH1A1ALOX15MAPT
SCHEMBL12494089 0.69 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14857298 0.68 RAB9A (0.50) NPC1RAB9AALDH1A1LMNAMAPT
SCHEMBL8687091 0.68 CYP4F2 (0.46) NPC1RAB9AALDH1A1MAPK1LMNA
SCHEMBL12494148 0.68 PSEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12494150 0.68 PSEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27652406 0.68 LCK (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3236449 0.68 MAPT (0.65) NPC1RAB9AALDH1A1MAPK1ALOX15
SCHEMBL32685467 0.68 MAPT (0.65) NPC1RAB9AALDH1A1MAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096885-A EXHIBIT AGONIST ACTIVITY FOR CCK-A RECEPTORS THEREBY ENABLING THEM TO MODULATE THE HORMONES GASTRIN AND CHOLECYSTOKININ IN MAMMALS. GLAXO WELLCOME INC. (US) 2000-08-01 — — US disclosed
EP-0785944-A1 ACYL AMINO ACETAMIDE DERIVATIVES WITH AGONIST ACTIVITY FOR CCK-A RECEPTORS GLAXO WELLCOME INC. (US) 1997-07-30 — — EP disclosed
WO-1996011940-A1 ACYL AMINO ACETAMIDE DERIVATIVES WITH AGONIST ACTIVITY FOR CCK-A RECEPTORS GLAXO WELLCOME INC. (US) 1996-04-25 — — WO disclosed
Send feedback